Kremer J - Search Results

1

A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.

Burmester GR, McInnes IB, Kremer J, Miranda P, Korkosz M, Vencovsky J, Rubbert-Roth A, Mysler E, Sleeman MA, Godwood A, Sinibaldi D, Guo X, White WI, Wang B, Wu CY, Ryan PC, Close D, Weinblatt ME; EARTH EXPLORER 1 study investigators. Burmester GR, et al. Among authors: kremer j. Ann Rheum Dis. 2017 Jun;76(6):1020-1030. doi: 10.1136/annrheumdis-2016-210624. Epub 2017 Feb 17. Ann Rheum Dis. 2017. PMID: 28213566 Free article. Clinical Trial.

2

Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.

Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling R. Weinblatt ME, et al. Among authors: kremer jm. J Rheumatol. 1992 Oct;19(10):1537-41. J Rheumatol. 1992. PMID: 1334515 Clinical Trial.

3

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months.

Kremer JM, Phelps CT. Kremer JM, et al. Arthritis Rheum. 1992 Feb;35(2):138-45. doi: 10.1002/art.1780350203. Arthritis Rheum. 1992. PMID: 1734902

4

Clinical studies of omega-3 fatty acid supplementation in patients who have rheumatoid arthritis.

Kremer JM. Kremer JM. Rheum Dis Clin North Am. 1991 May;17(2):391-402. Rheum Dis Clin North Am. 1991. PMID: 1862247 Review.

5

Severe rheumatoid arthritis: current options in drug therapy.

Kremer JM. Kremer JM. Geriatrics. 1990 Dec;45(12):43-8. Geriatrics. 1990. PMID: 2123816 Review.

6

Methotrexate therapy in the treatment of rheumatoid arthritis.

Kremer JM. Kremer JM. Rheum Dis Clin North Am. 1989 Aug;15(3):533-56. Rheum Dis Clin North Am. 1989. PMID: 2672136 Review.

7

Methotrexate in rheumatoid arthritis.

Weinblatt ME, Kremer JM. Weinblatt ME, et al. Among authors: kremer jm. J Am Acad Dermatol. 1988 Jul;19(1 Pt 1):126-8. doi: 10.1016/s0190-9622(88)80220-2. J Am Acad Dermatol. 1988. PMID: 3042815 Review. No abstract available.

8

Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study.

Kremer JM, Davies JM, Rynes RI, Fink S, Lawrence DA, Petrillo GF, Mullaly PM. Kremer JM, et al. Arthritis Rheum. 1995 May;38(5):601-7. doi: 10.1002/art.1780380504. Arthritis Rheum. 1995. PMID: 7748214 Clinical Trial.

9

Lack of a renal-protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Results of a randomized, placebo-controlled trial.

Weinblatt ME, Germain BF, Kremer JM, Wall BA, Weisman MH, Maier AL, Coblyn JS. Weinblatt ME, et al. Among authors: kremer jm. Arthritis Rheum. 1994 Sep;37(9):1321-5. doi: 10.1002/art.1780370908. Arthritis Rheum. 1994. PMID: 7945495 Clinical Trial.

10

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.

Kremer JM, Alarcón GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME. Kremer JM, et al. Arthritis Rheum. 1994 Mar;37(3):316-28. doi: 10.1002/art.1780370304. Arthritis Rheum. 1994. PMID: 8129787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters